l-carnitine tmao γ-Butyrobetaine Is a Proatherogenic Intermediate in Gut Microbial Metabolism of to Frontiers | Gut Microbiota-Dependent Marker

The increase in the scope of applications as well as the advent of more advanced analytical methods and of dedicated irradiation equipment has fostered growing interest on a variety of new scientific issues and technological perspectives

A patient-derived glioblastoma organoid model and biobank recapitulates inter- and intra-tumoral heterogeneity

10.1038/s41586-024-07516-8 [DOI] [PMC free article] [PubMed] [Google Scholar] Camille C., Goff Ocane L., Frdric S., Vasseur F., Tanou M., Nguyen C., et al

Differences exist regarding the type of maltreatment that must be reported and, in some cases, the source of the maltreatment

It should be noted that these fluorescence-based biodistribution studies provide qualitative and semi-quantitative information on local retention and tissue distribution rather than quantitative pharmacokinetic data, and no conclusions regarding systemic absorption or clearance kinetics were drawn from these experiments [34]

[DOI] [PubMed] [Google Scholar] 114.Duque-Guimaraes DE & Ozanne SE Nutritional programming of insulin resistance: causes and consequences